Morphine Titration by Patient Self-controlled by a Mechanical Device Versus Administration by the Nurse for Patients With Severe Acute Pain in the Emergency Department
NCT ID: NCT02152176
Last Updated: 2016-06-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
200 participants
INTERVENTIONAL
2014-07-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the recommendations formalized experts, it is recommended to use a protocol titration with morphine bolus of 2 mg (for patients less than 60 kg) or 3 mg (for patients over 60 kg) repeated every 5 minutes with a target of the Visual Analog Scale less than or equal to 30.
Despite these specific recommendations and a broad awareness of the teams, management of pain remains to be improved, the major difficulty of morphine titration at the emergency department being the availability of paramedical personnel to perform revaluations and reinjection. Thus, effective analgesia would be obtained in 50% of cases to 30 minutes.
The investigators want to study the self-controlled morphine titration by the patient by a mechanical device for single use (efficacy/safety).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg
NCT00237731
Titrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings
NCT02200185
Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department
NCT03257319
Effectiveness and Feasibility of Patient Controlled Analgesia in the ED
NCT01775371
Efficacy Study of Nebulized Morphine and Intravenous Morphine in Post Traumatic Pain
NCT01123551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Controlled Analgesy group
Titration of morphine by Patient Controlled Analgesy. The opioid titration will be performed by the patient using PCA (Vygon Freedom 5) according to the principle of self with a refractory period of 5 minutes.
Titration of morphine by Patient Controlled Analgesy
PCA is never used for titration but only for relay of titration. Self-controlled analgesia by PCA is our intervention.
Control group
titration will be perform in the usual manner in accordance with the recommendations : a nurse will assess pain using a visual analog scale in the control group to assess the need for a new bolus of morphine
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Titration of morphine by Patient Controlled Analgesy
PCA is never used for titration but only for relay of titration. Self-controlled analgesia by PCA is our intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute pain (Visual Analog Scale \> 60)
* Able to assess pain using the numerical scale
* Prescription of morphine titration
Exclusion Criteria
* History of allergy to morphine / hypersensitivity to any component
* Long-term treatment morphine
* Opioid therapy administered prior to inclusion
* Analgesic treatment level 2 (codeine, tramadol, nefopam ...) administered prior to inclusion or planned
* History of Substance Abuse
* Severe respiratory insufficiency
* Severe hepatic impairment
* Head trauma
* Intracranial hypertension
* Uncontrolled epilepsy
* Pregnant or lactating
* Patient jailed
* Incapacitated adult under guardianship
* Incapable of giving informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ROY Pierre-Marie, MD-PhD
Role: STUDY_CHAIR
UH Angers
SCHOTTE Thibault, Physician
Role: PRINCIPAL_INVESTIGATOR
UH Angers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SCHOTTE Thibault
Angers, , France
CHOUKROUN Jacques
Le Mans, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOI 2013-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.